PI3Kα/HDAC6-IN-1 is a dual PI3Kα/HDAC6 inhibitor with potent anticancer activity; it effectively inhibits the L-363 cell line (IC50 = 0.17 μM); suppresses AKT (Ser473) phosphorylation; and induces accumulation of acetylated α-tubulin without affecting acetylated histones H3 and H4.